Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

Summary

This phase II trial is studying how well CCI-779 works in treating patients with progressive metastatic neuroendocrine tumors. Drugs used in chemotherapy, such as CCI-779, work in different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start

2003-12

Primary completion

2011-04

Completion

2011-04

Drugs

Indications